Treatment of 22q11.2 deletion syndrome with cannabidiol

摘要

The present technology provides a method of treating one or more behavioral symptoms (eg, anxiety) of 22q11.2 deletion syndrome in a subject by, for example, transdermally administering to the subject an effective amount of cannabidiol (CBD), wherein the 22q11.2 One or more behavioral symptoms of deletion syndrome are treated.